CONGIA, MATTIA
 Distribuzione geografica
Continente #
EU - Europa 43.233
NA - Nord America 1.846
AS - Asia 1.029
SA - Sud America 155
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 46.291
Nazione #
IT - Italia 42.764
US - Stati Uniti d'America 1.803
SG - Singapore 389
CN - Cina 299
VN - Vietnam 130
BR - Brasile 121
SE - Svezia 106
DE - Germania 95
FI - Finlandia 54
GB - Regno Unito 48
FR - Francia 45
HK - Hong Kong 40
UA - Ucraina 28
IQ - Iraq 25
CA - Canada 24
IN - India 22
ES - Italia 20
JP - Giappone 20
NL - Olanda 19
BD - Bangladesh 17
KR - Corea 14
MX - Messico 10
CO - Colombia 9
ZA - Sudafrica 9
AR - Argentina 8
PK - Pakistan 8
AT - Austria 7
CL - Cile 7
DK - Danimarca 7
ID - Indonesia 7
UZ - Uzbekistan 7
JO - Giordania 6
PL - Polonia 6
CZ - Repubblica Ceca 5
EC - Ecuador 5
IL - Israele 5
IR - Iran 5
MA - Marocco 5
RU - Federazione Russa 5
TR - Turchia 5
AZ - Azerbaigian 4
GR - Grecia 4
IE - Irlanda 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
DZ - Algeria 3
EG - Egitto 3
KG - Kirghizistan 3
PH - Filippine 3
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
CH - Svizzera 2
CR - Costa Rica 2
ET - Etiopia 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
LV - Lettonia 2
MY - Malesia 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
PY - Paraguay 2
A1 - Anonimo 1
AU - Australia 1
BO - Bolivia 1
BZ - Belize 1
KH - Cambogia 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LT - Lituania 1
LY - Libia 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
TN - Tunisia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 46.291
Città #
Cagliari 41.440
Uta 1.159
Dallas 274
Singapore 227
Ashburn 214
San Jose 116
Chandler 95
Boardman 88
Fairfield 87
Beijing 63
Los Angeles 59
Nyköping 57
Woodbridge 54
Houston 48
The Dalles 48
Helsinki 44
Shanghai 43
New York 40
Council Bluffs 37
Hong Kong 34
Wilmington 34
Cambridge 33
Ho Chi Minh City 33
Munich 33
Santa Clara 32
Ann Arbor 30
Hanoi 27
Chicago 24
Lauterbourg 24
Boston 23
Seattle 22
Rome 20
Dearborn 18
Dong Ket 18
Hefei 18
Buffalo 17
Tokyo 16
Nuremberg 14
Guangzhou 13
Orem 13
Frankfurt am Main 12
Seoul 12
Denver 11
Jacksonville 11
Madrid 11
Milan 11
Baghdad 10
Brooklyn 10
London 10
San Diego 10
Montreal 9
Toronto 9
Amsterdam 8
Da Nang 8
Elk Grove Village 8
Erbil 8
Redondo Beach 8
São Paulo 8
Tashkent 7
Haiphong 6
Paris 6
Phoenix 6
Salt Lake City 6
Turku 6
Warsaw 6
Chennai 5
Mexico City 5
Miami 5
Mumbai 5
Poplar 5
San Mateo 5
Sestu 5
Amman 4
Athens 4
Atlanta 4
Cape Town 4
Changsha 4
Charlotte 4
City of London 4
Düsseldorf 4
Jeddah 4
Kiryat Ono 4
Leawood 4
Redwood City 4
Rio de Janeiro 4
Santiago 4
Shenzhen 4
Vancouver 4
Vienna 4
Zola Predosa 4
Baku 3
Belo Horizonte 3
Bexley 3
Bishkek 3
Brno 3
Dhaka 3
Gravataí 3
Guayaquil 3
Johannesburg 3
Laurel 3
Totale 45.043
Nome #
FRI0357 DRUG-INDUCED REMISSION AND SUBCLINICAL ACTIVITY IN PSORIATIC ARTHRITIS: TRANSCRIPTIONAL PROFILING TO CHARACTERIZE THE DISEASE STATE 10.743
Assessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet's Syndrome 3.172
Gene expression profiling of monozygotic twins affected by psoriatic arthritis 3.060
Expression analysis of HLA-E and NKG2A and NKG2C receptors points at a role for natural killer function in ankylosing spondylitis 3.055
Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus 2.903
Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus 2.332
null 2.245
null 1.791
Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study 1.645
Treatment target in newly diagnosed systemic lupus erythematosus: The association of lupus low disease activity state and remission with lower accrual of early damage 1.571
Targeted Therapies in Axial Psoriatic Arthritis 1.170
Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis 1.145
Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study 1.060
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus 1.044
Effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study 1.039
Imbalanced MMP-3 and MMP-12 serum levels in systemic lupus erythematosus patients with Jaccoud's arthropathy and a distinctive MRI pattern 989
Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review 927
Telemedicine in rheumatology: high specificity and sensitivity of follow-up virtual video consultations during COVID-19 pandemic 906
Patterns of Anti-Inflammatory and Immunomodulating Drug Usage and Microvascular Endothelial Function in Rheumatoid Arthritis 891
The Challenging Differentiation of Psoriatic Arthritis from Other Arthropathies and Nonspecific Arthralgias in Patients with Psoriasis: Results of a Cross-Sectional Rheumatologic Assessment of a Large Dermatologic Cohort 767
SAT0035 IS PHARMACOLOGICAL CLINICAL REMISSION SYNONYMOUS WITH BIOLOGICAL INACTIVE DISEASE? DIFFERENTIAL GENE EXPRESSION ANALYSIS IN RHEUMATOID ARTHRITISAND HEALTY CONTROLS 712
Ultrasonographic assessment of bone erosions in the different subtypes of systemic lupus erythematosus arthritis: Comparison with computed tomography 668
Predictors of musculoskeletal flares and Jaccoud׳s arthropathy in patients with systemic lupus erythematosus: A 5-year prospective study 540
Treatment of psoriasis with different classes of biologics reduces the likelihood of peripheral and axial psoriatic arthritis development 532
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial 522
B Cell Synovitis and Clinical Phenotypes in Rheumatoid Arthritis: Relationship to Disease Stages and Drug Exposure 395
Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials 360
Stratifying patients by TNFSF13B genotype revealed increased flare and renal flare risk, but a greater benefit from belimumab: a potential biomarker for personalized treatment in systemic lupus erythematosus 169
The metabolomic profile of psoriatic arthritis patients unveils the unbalance of disease-related molecules and pathways 50
Ultrasound-Guided Synovial Biopsy Can Be Effectively and Safely Performed in Different Clinical Settings Favouring a Widespread Application of Precision Medicine in Rheumatoid Arthritis: A Post-hoc Analysis of Three Clinical Trials 32
Totale 46.435
Categoria #
all - tutte 58.539
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.539


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021825 0 0 0 0 0 0 0 0 0 325 333 167
2021/20222.284 175 102 71 88 177 131 92 137 231 279 432 369
2022/20233.526 333 525 414 300 307 405 183 247 211 228 238 135
2023/20246.285 177 188 203 447 578 653 665 1.890 242 269 525 448
2024/202519.866 7.943 4.953 3.888 987 525 528 575 55 80 85 149 98
2025/20262.355 178 181 306 185 227 166 435 218 212 247 0 0
Totale 46.435